Načítá se...
Therapies targeting DNA and RNA in Huntington's disease
No disease-slowing treatments exist for Huntington’s disease (HD), but its monogenic inheritance makes it an appealing candidate for the development of therapeutics targeting pathogenic processes close to its root genetic cause. HD is caused by CAG repeat expansions in the HTT gene, which encodes hu...
Uloženo v:
| Vydáno v: | Lancet Neurol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5604739/ https://ncbi.nlm.nih.gov/pubmed/28920889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(17)30280-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|